Dr Reddy’s Laboratories Limited

Hyderabad, Sept.9 (Maxim News): Dr. Reddy’s Laboratories Ltd. today announced the launch of Remdesivir, under a brand name Redyx in India. The launch is part of the licensing agreement with Gilead Sciences, Inc. (Gilead) that grants Dr.…

Hyderabad, Aug.19 (Maxim News): Dr. Reddy’s Laboratories Ltd. today announced the launch of Avigan (Favipiravir) 200 mg Tablets in India. The launch is part of the global licensing agreement with Fujifilm Toyama Chemical Co. Ltd. that…

Hyderabad, June 10 (Maxim News): Dr. Reddy's Laboratories Limited said today it has completed the acquisition of select divisions of Wockhardt Limited’s branded generics business in India and a few other international territories of Nepal,…

Hyderabad, April 14 (Maxim News): Dr. Reddy’s Laboratories Limited, along with its subsidiaries together on Tuesday announced the launch of authorized generic version of NitroDur (nitroglycerin) Transdermal Infusion System in the US Market.…

Hyderabad, April 13 (Maxim News): Dr. Reddy’s Laboratories Limited launched of Invista, formulation of Dasatinib that is bioequivalent to the innovator brand. It is indicated for the treatment of chronic accelerated or myeloid or lymphoid…